Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001371796-20-000002
Filing Date
2020-02-12
Accepted
2020-02-12 14:01:18
Documents
1
Effectiveness Date
2020-02-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7894
  Complete submission text file 0001371796-20-000002.txt   8910
Mailing Address 135 NEWBURY STREET FRAMINGHAM MA 01701
Business Address 135 NEWBURY STREET FRAMINGHAM MA 01701 508-283-1200
Solace Therapeutics Inc (Filer) CIK: 0001371796 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-360376 | Film No.: 20603204